Intralesional interferon alfa-2b in the treatment of basal cell carcinoma: Immunohistochemical study on cellular immune reaction leading to tumor regression
- 31 May 1991
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 24 (5), 731-734
- https://doi.org/10.1016/0190-9622(91)70111-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Interferons in dermatologyJournal of the American Academy of Dermatology, 1989
- Treatment of neoplastic skin lesions with intralesional interferonJournal of the American Academy of Dermatology, 1989
- An absence of human leukocyte antigen-DR and a decreased expression of β2-microglobulin on tumor cells of basal cell carcinoma: No influence on the peritumoral immune infiltrateJournal of the American Academy of Dermatology, 1989
- The Immunology of Basal Cell CarcinomaInternational Journal of Dermatology, 1988
- TREATMENT OF LARGE BASAL-CELL CARCINOMAS WITH INTRALESIONAL INTERFERON-ALPHA-2aThe Lancet, 1988
- Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinomaJournal of the American Academy of Dermatology, 1987
- Treatment of basal cell carcinoma with intralesional interferonJournal of the American Academy of Dermatology, 1986
- Interferon enhances antibody-dependent cellular cytotoxicity when suboptimal concentrations of antibody are usedCellular Immunology, 1984
- Interferon: Status in treatment of skin diseaseJournal of the American Academy of Dermatology, 1980
- On the varied biologic effects of interferonCellular Immunology, 1977